PartnershipUpdated on 13 August 2025

Early detection of kidney injury

Bülent BIDI

CEO at Argeron Medikal Araştırma Sanayi ve Ticaret A.Ş.

Antalya, Türkiye

About

The solution is used in conjunction with common urine glucose measurement kits to determine trehalase activity, a key marker of kidney function. By analyzing this specific enzyme, Argeron Nephrotest helps healthcare professionals identify potential acute kidney injury at an early stage. This is particularly useful for hospitalized and intensive care patients, where early detection can lead to timely intervention and improved outcomes.

Looking for

  • Research and Development
  • Technology Transfer
  • Technology Trials / Testing

Similar opportunities